Results 221 to 230 of about 1,092,864 (243)

Replication protein A protects lagging strand gaps, restricting PARP inhibitor-induced synthetic lethality in BRCA1-deficient tumors. [PDF]

Nucleic Acids Res
VanderVere-Carozza PS, Jordan MR, Garrett JE, Pollok KE, Pawelczak KS, Turchi JJ.   +5 more
europepmc   +1 more source

Establishment of novel cholangiocarcinoma cell lines with ARID1A deficiency and preclinical validation of synthetic lethality therapies. [PDF]

Sci Rep
Prasopporn S, Sittithumcharee G, Chanthercrob J, Limsrichamrern S, Hirankitti A, More-Krong P, Sathirareuangchai S, Chaiboonchoe A, Sampattavanich S, Okada S, Jirawatnotai S.   +10 more
europepmc   +1 more source

Beyond synthetic lethality in large-scale metabolic and regulatory network models via genetic minimal intervention set. [PDF]

Bioinform Adv
Barrena N, Rodriguez-Flores C, Valcárcel LV, Olaverri-Mendizabal D, Agirre X, Prósper F, Planes FJ.   +6 more
europepmc   +1 more source

Correction to: Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer. [PDF]

Protein Cell
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome

Cell, 2021
Kenneth Aldape, Joo S Lee, Raanan Berger
exaly  

Capitalizing on Synthetic Lethality of MYC to Treat Cancer in the Digital Age

Trends in Pharmacological Sciences, 2021
Dexter Kai Hao Thng, Edward K Chow, Tan Boon Toh   +2 more
exaly  

What’s Next for the Synthetic Lethality Drug Discovery Engine?

Nature Reviews Drug Discovery, 2022
Asher Mullard
exaly  

Comprehensive Prediction of Robust Synthetic Lethality Between Paralog Pairs in Cancer Cell Lines

Cell Systems, 2021
David J Adams, Barbara De Kegel, Colm J. Ryan   +2 more
exaly